
A batch can pass every specification and still tell you that something is changing. Trending is how a quality system hears it. Why the guide[…]

An out-of-specification result is not a retest waiting to happen. It is a potential quality signal, and how you handle the first hours decides whether[…]

Every manufacturing site has deviations. What inspectors look at is whether yours are classified consistently, investigated in proportion to their risk, and traced to a[…]

eCTD v4.0 changes how submissions are structured and exchanged, but it does not change what a good dossier needs. Companies that treat the move as[…]

Modules 4 and 5 hold the data, but Module 2 holds the argument. The non-clinical and clinical overviews are usually the first documents an assessor[…]

A list of questions is not a rejection. It is the authority telling you what it needs in order to say yes. The quality of[…]

A gap analysis is the cheapest quality control you will ever buy. Done before submission, or before acquiring a product, it tells you what the[…]

Moving a medicine from prescription-only to non-prescription status is a regulatory variation with a strategic payload. The authority has to be satisfied that patients can[…]

A hybrid application sits between a generic and a full dossier. It relies on the reference product for part of the evidence and on your[…]

A well-established use application under Article 10a of Directive 2001/83/EC lets you replace your own non-clinical and clinical studies with published literature. It is a[…]